A Multicentre, Randomised Controlled Trial of Exenatide Versus Standard Care in Acute Ischemic Stroke (TEXAIS)
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2019
Price : $35 *
At a glance
- Drugs Exenatide (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms TEXAIS
- 20 Aug 2019 Planned End Date changed from 31 Dec 2020 to 31 Dec 2021.
- 20 Aug 2019 Planned primary completion date changed from 31 Dec 2019 to 31 Dec 2020.
- 08 Feb 2019 According to the trial design presented at the International Stroke Conference 2019, over 40 patients have been enrolled to date